Skip to content
10-Q

Quarterly Report

MOMENTA PHARMACEUTICALS INC

0001235010-20-000012

← back to feed
Filed
May 7, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Apr 23, 2020 117.71M sh
Capex Q1 2020 · Mar 31, 2020 $857K
Capex Q1 2020 · Mar 31, 2019 $137K
Operating Cash Flow Q1 2020 · Mar 31, 2020 −$64.62M
Operating Cash Flow Q1 2020 · Mar 31, 2019 −$37.59M
Cash And Equivalents Q1 2020 · Mar 31, 2020 $179.69M
Cash And Equivalents Q1 2020 · Dec 31, 2019 $382.52M
Stockholders Equity Q1 2020 · Mar 31, 2020 $428.19M
Stockholders Equity Q1 2020 · Dec 31, 2019 $454.46M
Stockholders Equity Q1 2020 · Mar 31, 2019 $422.56M
Stockholders Equity Q1 2020 · Dec 31, 2018 $461.01M
Current Liabilities Q1 2020 · Mar 31, 2020 $83.16M
Current Liabilities Q1 2020 · Dec 31, 2019 $106.1M
Total Liabilities Q1 2020 · Mar 31, 2020 $140.55M
Total Liabilities Q1 2020 · Dec 31, 2019 $163.91M
Current Assets Q1 2020 · Mar 31, 2020 $490.35M
Current Assets Q1 2020 · Dec 31, 2019 $539.13M
Total Assets Q1 2020 · Mar 31, 2020 $568.75M
Total Assets Q1 2020 · Dec 31, 2019 $618.37M
Sga Expense Q1 2020 · Mar 31, 2020 $14.56M
Sga Expense Q1 2020 · Mar 31, 2019 $24.21M
Rd Expense Q1 2020 · Mar 31, 2020 $34.21M
Rd Expense Q1 2020 · Mar 31, 2019 $27.97M
Operating Income Q1 2020 · Mar 31, 2020 −$40.67M
Operating Income Q1 2020 · Mar 31, 2019 −$48.09M
Revenue Q1 2020 · Mar 31, 2020 $8.89M
Revenue Q1 2020 · Mar 31, 2019 $4.11M